Needle-Free Injection Market Growth, Overview With Detailed Analysis 2022-2028

Precision Business Insights published a research report on "Needle-Free Injection Market: By Product (Fillable and Prefilled), Source of Power (Spring-based Injector Systems and Gas Propelled/Air Forced Injector Systems), Type (Liquid-based, Projectile/Depot-based, and Powder-based), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, and Pain Management), and End User (Hospitals & Clinics, Home Care Settings, and Research Laboratories) - Global/Region/Country Forecast to 2028"

Needle-free injection (NFI) is a comparatively recent technology that uses a small, precise fluid stream to deliver medications or vaccinations intramuscularly or subcutaneously. Self-administration of pharmaceuticals and the removal of needle fear are two advantages of the needle-free injection technique. The term "needle-free injection systems" refers to a variety of medication delivery devices that do not require the use of needles. It is feasible to inject highly viscous drugs that cannot be administered with ordinary syringe devices.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-needle-free-injection-market/

Chronic diseases, as well as lifestyle disorders, are becoming more common around the world. Several chronic diseases have become more common in the previous decade, necessitating lengthy hospital stays in some situations. Cancer, renal failure, and heart disease are only a few of the main chronic diseases. Hypertension, diabetes, cholesterol, & overweight/obesity are just a few of the lifestyle disorders that are becoming substantial risk factors. The occurrence of chronic diseases has reached alarming levels among Indians as a result of rapid economic growth and rising westernisation of lifestyle in recent decades. This has resulted in an increase in the demand for long-lasting medical equipment. Several universities, clinics, and research institutes across the world are partnering and financing needle-free jet injection experiments, mostly in the United States, the Great Britain, and China. Takeda & Portal Instruments announced a partnership in 2017 to create a needle-free medicine delivery system. As a result, with more partnerships and technological advancements, the trend toward self-administration of pharmaceuticals is likely to grow during the projection period.

In terms of type, the needle free injection systems market is segmented into liquid-based needle-free injectors, projectile/depot-based needle-free injectors, and powder-based needle free injectors. Needle free injection systems market has also been divided based on the product into fillable needle-free injectors and prefilled needle-free injectors. In terms of technology, the needle free injection systems market is segmented into jet-based needle-free injectors, spring-based needle-free injectors, laser-powered needle-free injectors and vibration-based needle-free injectors. In terms of site of delivery, the needle free injection systems market is fragmented into subcutaneous injectors, intradermal injectors and intramuscular injectors. In terms of usability, the needle free injection systems market is segmented into disposable needle-free injectors and reusable needle-free injectors. In terms of end user, the needle free injection systems market is categorized into hospitals and clinics, research laboratories, home care settings, pharmaceutical as well as biotechnological companies and other. In terms of application, the needle free injection systems market is classified into insulin delivery, oncology, vaccine delivery, and pain management and other.

Due to increased R&D spending, North America dominates the needle-free injection systems market, whereas Europe is expected to grow at the highest rate from 2022 to 2029 owing to increase demand for biologics, increasing incidence of chronic diseases, technological developments, acquisitions and mergers by key market players, favorable government initiatives, cost of medical care, and regulatory standards.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=36215

There are several industry players working in the Needle Free Injection Market, which include Antares Pharma, , (U.S.) Crossject needle-free injection systems ( France) D'Antonio Consultants International Inc. (U.S.) European Pharma Group (Netherlands) Endo Pharmaceuticals Inc. (Ireland) INJEX Pharma GmBH. (Germany) Medical International Technology, Inc., (Canada) National Medical Products Inc., (Saudi Arabia) Mika Medical Co., (Korea) PenJet Corporation. (U.S.)

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.